Candriam Equities L Oncology Impact, N - Capitalisation
WKN A3D92J | ISIN LU2346866317 | Fonds
Fonds
| ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
|---|---|---|---|---|---|---|
| 1 | LU2384387564 | CPR Invest - MedTech - A HUF - Acc | +27,68 % | +14,18 % | 1,77 |
|
| 2 | LU2036817398 | CPR Invest - MedTech - I EUR - Acc | +22,56 % | +12,20 % | 1,63 |
|
| 3 | LU2036817711 | CPR Invest - MedTech - R EUR - Acc | +22,09 % | +12,20 % | 1,60 |
|
| 4 | LU2194372772 | Bellevue Funds (Lux) - Bellevue Medtech & Services U2 CHF - Accumulating | +24,01 % | +13,46 % | 1,59 |
|
| 5 | LU2125047428 | CPR Invest - MedTech - M2 EUR - Acc | +21,93 % | +12,20 % | 1,58 |
|
| 434 | LU2091933452 | JPMorgan Funds - Thematics - Genetic Therapies D (acc) - EUR (hedged) | -9,41 % | +21,09 % | -0,57 |
|
| 435 | LU2053353582 | JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - CHF (hedged) | -10,07 % | +21,07 % | -0,60 |
|
| 436 | LU2098775385 | JPMorgan Funds - Thematics - Genetic Therapies C (acc) - CHF (hedged) | -10,15 % | +21,07 % | -0,61 |
|
| 437 | LU2053353400 | JPMorgan Funds - Thematics - Genetic Therapies A (acc) - CHF (hedged) | -10,56 % | +21,07 % | -0,63 |
|
| 438 | LI0507461338 | GF Global Cannabis Opportunity Fund EUR | -24,77 % | +27,83 % | -0,98 |
|